1. Prognostic utility of the ovarian cancer secretome: a systematic investigation
   Pradnya R. Kamble et al, 2022, Archives of Gynecology and Obstetrics CrossRef
2. Combination of Selenite and Butyrate Enhances Efficacy Against Colon Cancer by Targeting ASCT2-Mediated Amino Acid Metabolism
   Jinling Cui et al, 2023, Biological Trace Element Research CrossRef
3. Heterologous avian system for quantitative analysis of Syncytin-1 interaction with ASCT2 receptor
   Kryštof Štafl et al, 2021, Retrovirology CrossRef
4. miR‑125b‑5p inhibits cell proliferation by targeting ASCT2 and regulating the PI3K/AKT/mTOR pathway in an LPS‑induced intestinal mucosa cell injury model
   Huiming Guo et al, 2021, Experimental and Therapeutic Medicine CrossRef
5. New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic
   Xiaojing Yang et al, 2022, Frontiers in Oncology CrossRef
6. Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
   Gyuntae Bae et al, 2023, Frontiers in Molecular Biosciences CrossRef
7. ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation
   Catarina Lopes et al, 2021, Cancers CrossRef
8. Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
   Rui Ni et al, 2023, Frontiers in Oncology CrossRef
9. Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications
   Marta Baczewska et al, 2022, International Journal of Molecular Sciences CrossRef
10. Glutamine metabolism-related genes predict prognosis and reshape tumor microenvironment immune characteristics in diffuse gliomas
    Huanhuan Fan et al, 2023, Frontiers in Neurology CrossRef